GlassScriptPhysician profile
Stephan J Vivian
NPI 1619975877
$1,800.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,434 · 2020: $320 · 2021: $27.65 · 2022: $18.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $612.70 | 2019 | |
| Cardiofocus, INC. | $293.65 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $221.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $174.16 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $138.23 | 2019-2022 | |
| Biosense Webster, INC. | $125.54 | 2019 | |
| Abbott Laboratories | $119.66 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $59.29 | 2019 | |
| Canon Medical Systems USA, INC. | $27.38 | 2019 | |
| Terumo Medical Corporation | $14.61 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.36 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Vivian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.